Terms: = Prostate cancer AND COL2A1, SEDC, MGC131516, COL11A3, AOM, ANFH, ENSG00000139219, 1280
28 results:
1. Extended pelvic lymph node dissection in robot-assisted radical prostatectomy is an independent risk factor for major complications.
Baas DJH; de Baaij JMS; Sedelaar JPM; Hoekstra RJ; Vrijhof HJEJ; Somford DM; van Basten JA
J Robot Surg; 2024 Mar; 18(1):140. PubMed ID: 38554195
[TBL] [Abstract] [Full Text] [Related]
2. Genome-wide repeat landscapes in cancer and cell-free DNA.
Annapragada AV; Niknafs N; White JR; Bruhm DC; Cherry C; Medina JE; Adleff V; Hruban C; Mathios D; Foda ZH; Phallen J; Scharpf RB; Velculescu VE
Sci Transl Med; 2024 Mar; 16(738):eadj9283. PubMed ID: 38478628
[TBL] [Abstract] [Full Text] [Related]
3. Associations between cardiorespiratory fitness in youth and the incidence of site-specific cancer in men: a cohort study with register linkage.
Onerup A; Mehlig K; Geijerstam AA; Ekblom-Bak E; Kuhn HG; Lissner L; Åberg M; Börjesson M
Br J Sports Med; 2023 Oct; 57(19):1248-1256. PubMed ID: 37582636
[TBL] [Abstract] [Full Text] [Related]
4. Findings on Diagnostic Magnetic Resonance Imaging Before Radiotherapy for prostate cancer.
Dahan J; Delouya G; Lambert C; Olivié DAR; Billiard JS; Taussky D
Can Assoc Radiol J; 2023 May; 74(2):382-387. PubMed ID: 36325740
[TBL] [Abstract] [Full Text] [Related]
5. A prospective phase-II trial of biweekly docetaxel plus androgen deprivation therapy in patients with previously-untreated metastatic castration-naïve prostate cancer.
Byeon S; Kim H; Jeon HG; Seo SI; Jeon SS; Lee HM; Lee SI; Park SH
BMC Cancer; 2021 Nov; 21(1):1281. PubMed ID: 34839812
[TBL] [Abstract] [Full Text] [Related]
6. A real-world comparison of docetaxel versus abiraterone acetate for metastatic hormone-sensitive prostate cancer.
Tsaur I; Heidegger I; Bektic J; Kafka M; van den Bergh RCN; Hunting JCB; Thomas A; Brandt MP; Höfner T; Debedde E; Thibault C; Ermacora P; Zattoni F; Foti S; Kretschmer A; Ploussard G; Rodler S; von Amsberg G; Tilki D; Surcel C; Rosenzweig B; Gadot M; Gandaglia G; Dotzauer R;
Cancer Med; 2021 Sep; 10(18):6354-6364. PubMed ID: 34374489
[TBL] [Abstract] [Full Text] [Related]
7. Does a novel diagnostic pathway including blood-based risk prediction and MRI-targeted biopsies outperform prostate cancer screening using prostate-specific antigen and systematic prostate biopsies? - protocol of the randomised study STHLM3MRI.
Nordström T; Jäderling F; Carlsson S; Aly M; Grönberg H; Eklund M
BMJ Open; 2019 Jun; 9(6):e027816. PubMed ID: 31201191
[TBL] [Abstract] [Full Text] [Related]
8. MicroRNAs as potential therapeutics to enhance chemosensitivity in advanced prostate cancer.
Lin HM; Nikolic I; Yang J; Castillo L; Deng N; Chan CL; Yeung NK; Dodson E; Elsworth B; Spielman C; Lee BY; Boyer Z; Simpson KJ; Daly RJ; Horvath LG; Swarbrick A
Sci Rep; 2018 May; 8(1):7820. PubMed ID: 29777112
[TBL] [Abstract] [Full Text] [Related]
9. Discovering cancer vulnerabilities using high-throughput micro-RNA screening.
Nikolic I; Elsworth B; Dodson E; Wu SZ; Gould CM; Mestdagh P; Marshall GM; Horvath LG; Simpson KJ; Swarbrick A
Nucleic Acids Res; 2017 Dec; 45(22):12657-12670. PubMed ID: 29156009
[TBL] [Abstract] [Full Text] [Related]
10. Manumycin A suppresses exosome biogenesis and secretion via targeted inhibition of Ras/Raf/ERK1/2 signaling and hnRNP H1 in castration-resistant prostate cancer cells.
Datta A; Kim H; Lal M; McGee L; Johnson A; Moustafa AA; Jones JC; Mondal D; Ferrer M; Abdel-Mageed AB
Cancer Lett; 2017 Nov; 408():73-81. PubMed ID: 28844715
[TBL] [Abstract] [Full Text] [Related]
11. Feasibility Assessment of Patient Reporting of Symptomatic Adverse Events in Multicenter cancer Clinical Trials.
Basch E; Dueck AC; Rogak LJ; Minasian LM; Kelly WK; O'Mara AM; Denicoff AM; Seisler D; Atherton PJ; Paskett E; Carey L; Dickler M; Heist RS; Himelstein A; Rugo HS; Sikov WM; Socinski MA; Venook AP; Weckstein DJ; Lake DE; Biggs DD; Freedman RA; Kuzma C; Kirshner JJ; Schrag D
JAMA Oncol; 2017 Aug; 3(8):1043-1050. PubMed ID: 28208174
[TBL] [Abstract] [Full Text] [Related]
12. Clinical impact of SPECT-CT on bone scintigraphy in oncology: Pattern approach.
Tuncel M; Lay Ergun E; Caglar Tuncali M
J BUON; 2016; 21(5):1296-1306. PubMed ID: 27837636
[TBL] [Abstract] [Full Text] [Related]
13. Unique mutation portraits and frequent col2a1 gene alteration in chondrosarcoma.
Totoki Y; Yoshida A; Hosoda F; Nakamura H; Hama N; Ogura K; Yoshida A; Fujiwara T; Arai Y; Toguchida J; Tsuda H; Miyano S; Kawai A; Shibata T
Genome Res; 2014 Sep; 24(9):1411-20. PubMed ID: 25024164
[TBL] [Abstract] [Full Text] [Related]
14. The effect of testosterone replacement therapy on prostate cancer: a systematic review and meta-analysis.
Cui Y; Zong H; Yan H; Zhang Y
Prostate Cancer Prostatic Dis; 2014 Jun; 17(2):132-43. PubMed ID: 24445948
[TBL] [Abstract] [Full Text] [Related]
15. Potent anti-cancer effects of citrus peel flavonoids in human prostate xenograft tumors.
Lai CS; Li S; Miyauchi Y; Suzawa M; Ho CT; Pan MH
Food Funct; 2013 Jun; 4(6):944-9. PubMed ID: 23673480
[TBL] [Abstract] [Full Text] [Related]
16. SPDEF functions as a colorectal tumor suppressor by inhibiting β-catenin activity.
Noah TK; Lo YH; Price A; Chen G; King E; Washington MK; Aronow BJ; Shroyer NF
Gastroenterology; 2013 May; 144(5):1012-1023.e6. PubMed ID: 23376423
[TBL] [Abstract] [Full Text] [Related]
17. Short-term androgen-deprivation therapy improves prostate cancer-specific mortality in intermediate-risk prostate cancer patients undergoing dose-escalated external beam radiation therapy.
Zumsteg ZS; Spratt DE; Pei X; Yamada Y; Kalikstein A; Kuk D; Zhang Z; Zelefsky MJ
Int J Radiat Oncol Biol Phys; 2013 Mar; 85(4):1012-7. PubMed ID: 22981709
[TBL] [Abstract] [Full Text] [Related]
18. Effectiveness of using fewer implanted fiducial markers for prostate target alignment.
Kudchadker RJ; Lee AK; Yu ZH; Johnson JL; Zhang L; Zhang Y; Amos RA; Nakanishi H; Ochiai A; Dong L
Int J Radiat Oncol Biol Phys; 2009 Jul; 74(4):1283-9. PubMed ID: 19427750
[TBL] [Abstract] [Full Text] [Related]
19. Predicting the outcome of prostate biopsy: comparison of a novel logistic regression-based model, the prostate cancer risk calculator, and prostate-specific antigen level alone.
Hernandez DJ; Han M; Humphreys EB; Mangold LA; Taneja SS; Childs SJ; Bartsch G; Partin AW
BJU Int; 2009 Mar; 103(5):609-14. PubMed ID: 19007374
[TBL] [Abstract] [Full Text] [Related]
20. Calcification of multipotent prostate tumor endothelium.
Dudley AC; Khan ZA; Shih SC; Kang SY; Zwaans BM; Bischoff J; Klagsbrun M
Cancer Cell; 2008 Sep; 14(3):201-11. PubMed ID: 18772110
[TBL] [Abstract] [Full Text] [Related]
[Next]
